Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829751 · ClinicalTrials.gov registry record · NA
The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility
A NA study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT00829751: Completed NA study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
NCT00829751 is a NA study that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829751, a NA study, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to more objectively evaluate potential lens-material/care solution bio-incompatibilities. We will do this by measuring corneal staining and the amount of fluorescein dye diffusion into the eye.
Interventions
- DEVICE PureVision lenses soaked in ReNu Multiplus
- DEVICE PureVision lenses soaked in OptiFree RePlenish
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT00829751 record still lists
NCT00829751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which PureVision lenses soaked in ReNu Multiplus is the first listed.
NCT00829751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829751 about?
NCT00829751 is a clinical study titled "The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility". The purpose of this study is to more objectively evaluate potential lens-material/care solution bio-incompatibilities. We will do this by measuring corneal staining and the amount of fluorescein dye diffusion into the eye.
What is the current status of trial NCT00829751?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2008-11. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00829751?
The interventions under investigation include: PureVision lenses soaked in ReNu Multiplus (DEVICE), PureVision lenses soaked in OptiFree RePlenish (DEVICE).
Who is sponsoring clinical trial NCT00829751?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829751's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia